CSI Market
Sign In | Register

Stablecoin Development (SDEV) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SDEV quarterly Cash Flow →
The data below summarizes Stablecoin Development's cash flow activity from Dec 31 2021 to Dec 31 2025, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-22.14
Depreciation & amortization0.00
Amortization of Other Assets0.25
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.85
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.03
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants24.49
Share Based Goods And Nonemployee Services Transaction Stockholders Equity-
Note Receivable Impairment-
Gain Loss Due To Change In Fair Value Of Warrant-
Stockbased Compensation Expense For Issuance Of Restricted Stock Units To Employees-
Operating Lease Impairment Loss-
Share Based Compensation Expense For Stock Option Modification-
Interest Expense Related To Amortization Of Debt Issuance Related To Related Party Notes Payable-
Derivative Gain Loss On Derivative Net-
Increase Decrease In Operating Lease Liabilities-
Increase Decrease In Deferred Rent-
Addition Of Operating Lease Rightofuse Asset-
Increase Decrease In Operating Lease Liability-0.40
Gain Loss On Termination Of Lease-
Income Loss From Held for Sale Assets-
Loss Income From Discontinued Operations Net Of Tax Attributable To Parent-11.08
Crypto Asset Unrealized Gain Operating-
Noncash Gain Loss On Warrant Liabilities In Excess Of Proceeds At Issuance0.14
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.04
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets-0.45
Other Working Capital-0.09
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-8.43
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.50
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-1.15
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock5.95
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net5.14
Proceeds From Exercise Of Options And Warrants-
Other Significant Noncash Transaction Value Of Consideration Given-
Stock Issued-
Proceeds From Sale Of Restricted Stock To Cover Taxes-
Proceeds From Sale Of Stock Options And Restricted Stock Sold To Cover Taxes-
Proceeds From Preferred Stock Issuances Net-
Proceeds From Debenture And Warrant Issuances Net-
Payments To Warrants Exchange-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-4.82
Net Cash Flow from Financing Activities4.62
Effect of exchange rate on cash flow-3.82
Discontinued operations0.00
Free Cash Flow-8.43
Total Cash Flow7.32
4 historic quarters locked

Sign in to unlock the full Stablecoin Development cash flow history.

Sign In Create Free Account

About Novabay Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-009090

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document